What did @busysuperhuman actually say?
The creator, who took up gymnastics in their 40s, says they investigated "so-called healing supplements" expecting injuries. They describe TB-500 as "a short synthetic version of the protein thymosin beta 4" and say its "main purpose is to promote healing and prevent injuries." They cite clinical trials involving tissue repair, stroke recovery, burns, and ulcers. Then, to their credit, they immediately walk some of that back: "there aren't much research on TB500 so there are no definitive studies to say or prove it works or it's 100% safe." The video ends with an anecdote: no injuries over four years of gymnastics in their 40s.
So the structure here is: big claim, partial disclaimer, personal testimonial. That's a pattern worth unpacking carefully, because the disclaimer doesn't fully neutralize the implied cause-and-effect between TB-500 and staying injury-free.
Does the science back this up?
Partially, but not in the way the video implies. The research on thymosin beta-4 (the parent protein) is real and reasonably promising in preclinical settings. The leap to TB-500 in healthy humans for injury prevention is not supported by clinical trial evidence.
Thymosin beta-4 has been studied for wound healing, cardiac repair, and corneal injury. Sosne et al. (2007, Cornea) showed TB4 accelerated corneal wound healing in animal models. Kim et al. (2010, Journal of Cardiovascular Pharmacology) found cardioprotective effects post-infarction in rats. A Phase II trial by RegeneRx Biopharmaceuticals examined thymosin beta-4 in dermal wound healing with modest positive signals, but the company halted further development.
TB-500 is a synthetic peptide fragment of thymosin beta-4, specifically the actin-binding domain. It is not the same molecule. There are no published Phase II or Phase III trials in humans using TB-500 specifically for musculoskeletal injury prevention in healthy adults. Most evidence sits at the in-vitro or rodent level. Using preclinical thymosin beta-4 data to vouch for TB-500 in human athletics is a meaningful scientific stretch.
What did they get wrong (or right)?
Let's separate the two. The creator got the basic chemistry roughly right: TB-500 is derived from thymosin beta-4, and the parent protein has been studied in tissue repair contexts. The self-aware disclaimer that there are "no definitive studies" is more honest than most peptide content on TikTok. Credit where it's due.
What they got wrong, or at least muddied, is the framing of clinical trials. Saying thymosin beta-4 "has been used successfully in clinical trials to involve tissue repair" overstates the evidence. The RegeneRx wound care trials showed mixed results, and none of them involved TB-500 or athletic injury prevention. Conflating thymosin beta-4 clinical data with TB-500 efficacy is a category error that could mislead viewers into thinking there's a human trial backing their specific use case.
The bigger issue is the testimonial ending. "I didn't get any injuries" after four years of gymnastics in your 40s is not evidence that TB-500 worked. It's one person's experience with no control condition. Plenty of people do recreational gymnastics injury-free without any peptide supplementation.
What should you actually know?
TB-500 is not approved by the FDA for any indication. It is not a licensed pharmaceutical product in the United States. It is prohibited by the World Anti-Doping Agency (WADA) under the S2 category of peptide hormones and growth factors, which matters if you compete in any tested sport.
Because TB-500 exists in a regulatory gray zone, products sold online vary wildly in purity and actual peptide content. A 2018 analysis by Holt et al. (Drug Testing and Analysis) found significant discrepancies between labeled and actual peptide concentrations in commercially available research peptides. You often don't know what you're injecting.
If you're genuinely interested in peptide therapies for recovery or tissue health, the appropriate path is a consultation with a licensed clinician who can review your health history, explain the off-label status of these compounds, and monitor you properly. Self-dosing based on a TikTok video, however well-intentioned, is a different thing entirely from supervised clinical use.
- TB-500 is not the same as thymosin beta-4. They share a structural fragment but are distinct compounds with different research profiles.
- No published human clinical trial has tested TB-500 specifically for athletic injury prevention in healthy adults.
- WADA bans TB-500 for competing athletes under the S2 prohibited list.
- Anecdotal injury-free outcomes cannot be attributed to a supplement without a controlled comparison.